Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Papillomavirus Vaccine Could Reduce Rate Of Vulval And Vaginal Cancers

18.05.2007
Administration of a quadrivalent human papillomavirus (HPV) vaccine has proven effective in preventing high-grade vulval and vaginal lesions that can lead to cancers in those areas, conclude authors of a study published in this week’s edition of The Lancet.

Professor Jorma Paavonen, Department of Obstetric and Gynecology, University Central Hospital, Helsinki, Finland, and colleagues carried out their analysis of three randomised clinical trials involving more than 18,000 women aged 16-26 years in 24 countries across Europe, Asia, and the Americas. The women were randomly assigned to receive either quadrivalent HPV6/11/16/18 vaccine or placebo.

The women were then followed up for an average of three years. Vaccine efficacy varied from 71% in women previously exposed to the human papillomaviruses to 100% in those not previously exposed. Additionally, a 49% reduction in all high-grade vulval and vaginal lesions, irrespective of casual HPV type, was seen in the intention-to-treat population of sexually active young women.

There has been a striking increase of high-grade vulval pre-cancer lesions and cancer over the past 30 years.

The authors say: “This trend is worrying because these cancers are not amenable to a screening programme. Whereas previously vulval cancer was seen almost exclusively in older women, recent studies have shown that 20% of these cancers now occur in women under 50 years.”

They add (although this quote is not within the article) “Vulval and vaginal cancers are often not recognised. Treatment of choice is surgery which can be mutilating, and causes anxiety, depression, sexual dysfunction and poor self image.”

They conclude: “In summary, these combined studies provide substantial evidence that a quadrivalent HPV L1 VLP vaccine is highly effective in preventing high-grade vulval and vaginal lesions associated with HPV16 or HPV18. The maximum effect of vaccination is expected in girls who are vaccinated in early adolescence, before exposure. The effect of vaccination in the general population of sexually experienced young women is expected to be lower initially, due to prevalent HPV infection.

“This intervention could greatly reduce the morbidity, mortality and health-care costs associated with these diseases.”

Tony Kirby | alfa
Further information:
http://www.thelancet.com
http://www.thelancet.com/webfiles/images/clusters/thelancet/press_office/Papillomavirus.pdf

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>